Dr. Deepti Sinha, MD

Dr. Sinha practices at Mid Peninsula Endoscopy Center in Burlingame, California.

Dr. Sinha's NPI, 1124213178, was assigned on September 12, 2007. Dr. Sinha graduated from University of Melbourne Faculty of Medicine in 1997. Dr. Sinha holds California license A104240.

Dr. Sinha's primary practice is Mid Peninsula Endoscopy Center, at 1720 El Camino Real, Suite 100, Burlingame, CA 94010. The practice phone is (650) 373-1970.

Dr. Sinha's primary practice is Mid Peninsula Endoscopy Center in Burlingame, California. The medical group on file is Lucile Packard Children's Hospital Stanford. Dmand AI also links Dr. Sinha to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sinha practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sinha's primary specialty in the NPI Registry, under taxonomy code 207RS0012X. The record also lists sleep medicine. Dr. Sinha is board certified in sleep medicine by the American Board of Family Medicine. Dmand AI has Dr. Sinha's licenses on file in 2 states: California and Illinois.

CMS data shows 240 Medicare services from Dr. Sinha across 5 procedure codes in 2024, for 162 Medicare patients. Medicare paid $50,655 for them. Every service was in an office.

CMS counts 162 Medicare patients who saw Dr. Sinha in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sinha's median patient age at 38, with 39% women.

In 2024, Dr. Sinha wrote 264 Medicare Part D claims for 44 patients. 83% of them were for generic drugs. CMS names the drug for 215 of them, across 10 drugs with 11 or more claims each, at $237,551 in total drug cost. In 2023, CMS named 147 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Sinha for performance year 2024, reported as part of a group. Dr. Sinha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sinha as offering telehealth.

Dmand AI links 11 papers to Dr. Sinha, published from 2011 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Head and Neck Neoplasms, Plastic Surgery Procedures and Sarcoma. Dr. Sinha has published most often in J Craniomaxillofac Surg.

Dmand AI links Dr. Sinha to 1 clinical trial. Conditions studied include Respiration Disorders and Respiratory Tract Diseases.

CMS Open Payments shows 39 general payments to Dr. Sinha from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. Jazz Pharmaceuticals Inc. paid the most, $404.

Dmand AI lists 1 award for Dr. Sinha, most recently CMS Stage 1 EHR in 2013.

Dr. Sinha graduated from University of Melbourne Faculty of Medicine in 1997.

Dr. Sinha is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.